Yidu Tech Inc. (HKG:2158)
Hong Kong · Delayed Price · Currency is HKD 4.570
+0.160 (3.63%)
Jul 31, 2026, 4:08 PM HKT
Yidu Tech Financials Overview
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 819.3 | 819.3 | 714.98 | 807.08 | 804.7 | 1,237 |
Revenue Growth | 10.17% | 14.59% | -11.41% | 0.29% | -34.96% | 42.69% |
Gross Profit Gross Profit Growth | 298.5 | 298.5 | 239.18 | 338.68 | 274.5 | 396.9 |
Operating Income Operating Income Growth | -73.89 | -73.89 | -302.65 | -351.84 | -605.67 | -759.83 |
Net Income Net Income Growth | 72.71 | 72.71 | -117.79 | -194.94 | -627.97 | -762.32 |
Earnings Per Share EPS Growth | 0.07 | 0.07 | -0.11 | -0.19 | -0.63 | -0.80 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
AI for Life Sciences AI for Life Sciences Growth | 270.42 | 270.42 | 247.11 | 324.04 | 252.88 | 359.38 |
AI for Medical AI for Medical Growth | 381.03 | 381.03 | 345.89 | 313.63 | 221.86 | 444.89 |
AI for Care AI for Care Growth | 167.85 | 167.85 | 121.98 | 169.4 | 329.95 | 424.94 |
Total Total Growth | 819.3 | 819.3 | 714.98 | 807.08 | 804.7 | 1,237 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,139 | 2,139 | 3,285 | 3,704 | 3,752 | 3,773 |
Total Debt Total Debt Growth | 71.09 | 71.09 | 129.54 | 95.2 | 14.13 | 52.17 |
Net Cash (Debt) Net Cash Growth | 2,068 | 2,068 | 3,155 | 3,608 | 3,738 | 3,721 |
Net Cash Growth | -1.77% | -34.46% | -12.55% | -3.47% | 0.46% | -19.09% |
Net Cash Per Share Net Cash Per Share Growth | 1.91 | 1.91 | 2.99 | 3.43 | 3.76 | 3.89 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -22 | -22 | -248.81 | -326.38 | -357.01 | -614.68 |
Capital Expenditures CapEx Growth | -12.28 | -12.28 | -101.81 | -39.23 | -17.59 | -57.47 |
Free Cash Flow Free Cash Flow Growth | -34.28 | -34.28 | -350.62 | -365.62 | -374.6 | -672.14 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 36.43% | 36.43% | 33.45% | 41.96% | 34.11% | 32.08% |
Operating Margin | -9.02% | -9.02% | -42.33% | -43.59% | -75.27% | -61.41% |
Pretax Margin | 10.24% | 10.24% | -18.87% | -27.41% | -78.16% | -61.98% |
Profit Margin | 8.88% | 8.88% | -16.47% | -24.15% | -78.04% | -61.62% |
FCF Margin | -4.18% | -4.18% | -49.04% | -45.30% | -46.55% | -54.33% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 57.99 | 60.58 | - | - | - | - |
Forward PE | 56.24 | 112.78 | - | - | - | - |
PS Ratio | 5.00 | 5.38 | 8.53 | 4.87 | 8.14 | 6.32 |